Your AI-Trained Oncology Knowledge Connection!
A chatbot-based approach was equivalent to SOC pretest cancer genetic services and genetic testing among individuals eligible for cancer genetic testing.
Manish R. Patel, MD, and Gottfried E. Konecny, MD, detail findings from studies evaluating CLDN6-directed agents that showed signals of promising efficacy and tolerability.
Experts break down emerging data for the use of quadruplet regimens in newly diagnosed multiple myeloma.
Coauthor of the Lancet Breast Cancer Commission report, Reshma Jagsi, MD, DPhil, details the 6 themes of the evidence-based plan aimed to address challenges in the field.
Maurie Markman, MD, delves into questions regarding precision medicine and genetic testing in cancer.
